Why CVS Health Lost 13% in the First Half of the Year
You might think that a healthcare leader like CVS Health (NYSE: CVS) would have been poised to outperform during the COVID-19 pandemic, but that has not been the case so far. Shares of the nation's largest drugstore chain and the parent of health insurer Aetna slipped 13% through the first six months of the year, according to data from S&P Global Market Intelligence, as pandemic-related uncertainty reigned over expectations.
Shares of CVS tracked similarly to the S&P 500 but underperformed the broad-market index for much of the year.
Source Fool.com